Cerebrovascular Diseases

Ticagrelor Wins Label Expansion to Reduce Risk of Recurrent Stroke, TIA
November 06, 2020

FDA approval is based on results of the phase III THALES trial, in which DAPT with ticagrelor and aspirin for 30 days reduced the rate of stroke and death by 17% vs aspirin alone.

Visit-to-Visit Variability in BP Associated with Dementia, Cognitive Decline
September 03, 2020

"Beyond hypertension, higher BPV is a major clinical predictor of cognitive impairment and dementia," conclude authors of a new study.

Home-based BP Measures Should Drive Treatment Decisions
June 30, 2020

Home blood pressure monitoring, performed accurately, is the key to data that will guide optimal hypertension treatment. Dr Naomi Fisher talks with Patient Care.